Intervention

tocilizumab [RoActemra/Actemra]

ClinicalTrials.gov intervention label

Clinical trials45
Recruiting0
Common conditions1
Lead sponsors shown1
Advertisement

Clinical trials

45 shown
A Study Assessing the Safety and Efficacy of Subcutaneous RoActemra/Actemra Alone or in Combination With Non-biologic Antirheumatics in Rhuematoid Arthritis Patients in Latin America With Inadequate Response to Non-biologic Antirheumatic Drugs.NCT02011334 · 2014-07-01
COMPLETED
A Study of Subcutaneous RoActemra/Actemra (Tocilizumab) as Monotherapy or in Combination With Methotrexate or Other Non-Biologic DMARDs in Patients With Active Rheumatoid ArthritisNCT01995201 · 2013-09-01
COMPLETED
A Study of The Effect of RoActemra/Actemra (Tocilizumab) in Combination With Methotrexate on Articular Damage in The Hand in Patients With Moderate to Severe Rheumatoid Arthritis Who Have an Inadequate Response to Non-Biological DMARDsNCT01878318 · 2013-06-01
WITHDRAWN
A Long-Term Extension Study of RoActemra/Actemra (Tocilizumab) in Patients With Early Moderate to Severe Rheumatoid Arthritis Who Completed Study WA19926NCT01730456 · 2012-10-01
COMPLETED
A Long-Term Safety Extension Study of WA19926 in Participants With Rheumatoid ArthritisNCT01649804 · 2012-07-01
COMPLETED
A Study of RoActemra/Actemra (Tocilizumab) With or Without Methotrexate in Patients With Mild to Moderate Rheumatoid Arthritis With an Inadequate Response to MethotrexateNCT01587989 · 2012-02-01
COMPLETED
A Study of RoActemra/Actemra (Tocilizumab) in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to DMARDs or Anti-TNFNCT01326962 · 2011-11-30
COMPLETED
A Study of RoActemra/Actemra (Tocilizumab) in Combination With DMARDs Versus Current Best Practice DMARD Therapy in Patients With Rheumatoid ArthritisNCT01251120 · 2011-11-01
TERMINATED
A Study of RoActemra/Actemra (Tocilizumab) in Patients With Moderate to Severe Rheumatoid ArthritisNCT01245439 · 2011-09-01
COMPLETED
A Study of RoActemra/Actemra (Tocilizumab) in Combination With Methotrexate Versus RoActemra/Actemra Monotherapy in Patients With Rheumatoid Arthritis and an Inadequate Response to MethotrexateNCT01399697 · 2011-09-01
COMPLETED
A Study of RoActemra/Actemra (Tocilizumab) Versus Adalimumab in Combination With Methotrexate (MTX) in Patients With Moderate to Severe Active Rheumatoid Arthritis And an Inadequate Response to Treatment With Only One Tumor Necrosis Factor (TNF)-InhibitorNCT01283971 · 2011-05-01
TERMINATED
A Study of RoActemra/Actemra (Tocilizumab) in Combination With Methotrexate in Patients With Active Rheumatoid Arthritis Who Have an Inadequate Response to Non-biologic DMARDsNCT01353859 · 2011-03-01
COMPLETED
A Study of RoActemra/Actemra and, if Initially Inadequately Responded to RoActemra/Actemra, Followed by MabThera/Rituxan in Patients With Rheumatoid ArthritisNCT01332994 · 2011-03-01
COMPLETED
A Study of RoActemra/Actemra (Tocilizumab) in Combination With Methotrexate in Patients With Active Rheumatoid Arthritis Who Have an Inadequate Response to Disease-Modifying Antirheumatic Drugs (DMARDs) (ALABASTER)NCT01235507 · 2011-02-01
COMPLETED
A Study of Glucocorticoid Use to Evaluate Systematic Methylprednisolone Reduction in Patients With Rheumatoid Arthritis on Background RoActemra/Actemra (Tocilizumab) (ACT-ALONE)NCT01219933 · 2011-01-01
COMPLETED
A Study of RoActemra/Actemra (Tocilizumab) in Patients With Active Rheumatoid Arthritis Who Have an Inadequate Response to Current Non-Biologic and/or Biologic DMARDSNCT01149057 · 2010-10-01
COMPLETED
A Study of RoActemra/Actemra (Tocilizumab) Plus DMARDs in Patients With Rheumatoid ArthritisNCT01214733 · 2010-10-01
COMPLETED
A Study of the Effects of RoActemra/Actemra (Tocilizumab) on Neutrophils in Patients With Active Rheumatoid Arthritis Who Have an Inadequate Response to Biologic and/or Non-biologic DMARDs.NCT01195272 · 2010-08-01
COMPLETED
A Study of Tocilizumab Plus Non-biological DMARD in Patients With Moderate to Severe Rheumatoid Arthritis and an Inadequate Response to Non-biological DMARDsNCT01034397 · 2010-03-01
COMPLETED
A Study of RoActemra/Actemra (Tocilizumab) in Adult Patients With Rheumatoid Arthritis (SVOBODA Programme)NCT02010216 · 2010-03-01
COMPLETED
A Study of RoActemra/Actemra (Tocilizumab) in Patients With Active Rheumatoid Arthritis Who Have an Inadequate Response to DMARDs (REMISSION)NCT01610791 · 2010-03-01
COMPLETED
A Study With Tocilizumab [RoActemra/Actemra] Monotherapy or in Combination With Methotrexate in Patients With Rheumatoid Arthritis (PICTURE)NCT01063062 · 2010-02-28
COMPLETED
A Study of Tocilizumab and Methotrexate in Combination or as Monotherapy in Treatment-Naïve Patients With Early Rheumatoid ArthritisNCT01034137 · 2010-01-01
COMPLETED
A Study of Tocilizumab as Monotherapy or in Combination With DMARDs in Patients With Moderate to Severe Active Rheumatoid ArthritisNCT01089023 · 2010-01-01
COMPLETED
A Study of Tocilizumab Added to DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis and an Inadequate Response to DMARDs.NCT00996203 · 2009-10-31
COMPLETED
A Study of Tocilizumab + DMARDs in Patients With Moderate to Severe Active Rheumatoid ArthritisNCT00951275 · 2009-10-31
COMPLETED
A Study of Subcutaneously Administered Tocilizumab in Patients With Rheumatoid ArthritisNCT00965653 · 2009-08-01
COMPLETED
TORPEDO Study: A Study on Rapid Effect of Tocilizumab in Patients With Rheumatoid Arthritis With an Inadequate Response to Disease-Modifying Antirheumatic Drugs (DMARDs) or Anti-TNFNCT00977106 · 2009-06-01
COMPLETED
A Study of Tocilizumab With or Without Methotrexate in Patients With Rheumatoid Arthritis.NCT01010503 · 2009-06-01
COMPLETED
A Study Comparing Infusion Rates of Tocilizumab in Patients With Moderate to Severe Rheumatoid ArthritisNCT00887341 · 2009-05-01
COMPLETED
A Study Of Tocilizumab in Patients With Moderate to Severe Active Rheumatoid Arthritis Who Have an Inadequate Response to or Are Unable to Tolerate Biologic and Non-Biologic Disease-modifying Antirheumatic Drugs (DMARDs)NCT00891020 · 2009-05-01
COMPLETED
A Study of Combination Treatment With MabThera (Rituximab) and RoActemra (Tocilizumab) Versus RoActemra in Patients With Rheumatoid Arthritis With an Incomplete Response to MethotrexateNCT00845832 · 2009-03-01
TERMINATED
An Extension to Study MA21573, Evaluating Tocilizumab in Patients With Active Rheumatoid Arthritis and an Inadequate Response to Current Non-Biological DMARDs and/or Anti-tumor Necrosis Factor (TNF) TherapyNCT00883753 · 2009-03-01
COMPLETED
A Study of Tocilizumab and Methotrexate Treatment Strategies (Adding Tocilizumab to Methotrexate Versus Switching to Tocilizumab) in Patients With Active Rheumatoid Arthritis With Inadequate Response to Prior Methotrexate TreatmentNCT00810199 · 2009-03-01
COMPLETED
A Study to Assess the Effect of Tocilizumab Plus Methotrexate on Safety and Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid ArthritisNCT00754572 · 2009-02-01
COMPLETED
A Study to Assess the Effect of Tocilizumab on Signs and Symptoms in Patients With Rheumatoid ArthritisNCT00848120 · 2008-12-31
COMPLETED
A Study of Tocilizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Current Non-Biologic DMARDsNCT00810277 · 2008-11-30
COMPLETED
A Study of Tocilizumab in Combination With DMARD Therapy in Patients With Active Rheumatoid Arthritis.NCT00773461 · 2008-10-31
COMPLETED
An Exploratory Study of Tocilizumab in Patients With Active Rheumatoid Arthritis (RA) and an Inadequate Response to Current Non-Biologic DMARDs and/or Anti-TNF Therapy.NCT00750880 · 2008-09-01
COMPLETED
A Study to Assess the Safety and Efficacy of Tocilizumab in Patients With Active Rheumatoid ArthritisNCT00109408 · 2005-07-01
COMPLETED
A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis Currently on Methotrexate TherapyNCT00106522 · 2005-05-01
COMPLETED
A Study to Assess the Effect of Tocilizumab + DMARD Therapy on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid ArthritisNCT00106574 · 2005-04-01
COMPLETED
A Study to Assess the Effect of Tocilizumab + Methotrexate on Prevention of Structural Joint Damage in Patients With Moderate to Severe Active Rheumatoid Arthritis (RA)NCT00106535 · 2005-01-01
COMPLETED
A Drug Interaction Study Between Tocilizumab, Methotrexate and Simvastatin on Patients With Rheumatoid Arthritis.NCT00365001
COMPLETED
A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid ArthritisNCT00106548
COMPLETED

Trial status mix

COMPLETED41
TERMINATED3
WITHDRAWN1

Phase mix

PHASE329
PHASE412
PHASE12
PHASE22
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.